Carbamazepine Tablet, Extended Release
Product Images NDC 51672-4125

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Carbamazepine (NDC 51672-4125). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Carbamazepine 01)

Chemical structure of carbamazepine, showing the fused aromatic rings and the amide functional group attached to the central ring system.*

FDA Label Image

Table 1 (Table 1)

A data table titled 'Risk by Indication for Antiepileptic Drugs in the Pooled Analysis' presenting the incidence of events per 1,000 patients for placebo and drug groups by indication (Epilepsy, Psychiatric, Other), along with relative risk and risk difference values comparing drug patients to placebo patients.*

FDA Label Image

Table (Table 2)

A dosing information table for Carbamazepine showing initial, subsequent, and maximum daily doses for different age groups and indications including Epilepsy (under 6 years, 6 to 12 years, over 12 years) and Trigeminal Neuralgia. The table distinguishes dosage forms as conventional tablets, extended-release tablets (XR), and suspensions, with doses given in mg or mL and administration frequencies detailed.*

FDA Label Image

Principal Display Panel (100 mg Tablet Bottle Label)

Label for Carbamazepine 100 mg chewable tablets, showing it is a prescription drug by Sun Pharmaceutical Industries, Inc. The label indicates storage instructions, pharmacist dispensing notes, and manufacturer details by Taro Pharmaceutical Industries Ltd. The package contains 500 tablets. Dosage and handling directions are also visible.*

FDA Label Image

Container Label (Carbamazepine Chewable 100 mg)

Carbamazepine Tablets USP (Chewable) 100 mg label from Sun Pharmaceutical Industries, Inc. The label includes directions to keep out of reach of children and mentions 100 tablets per container. It also provides storage instructions to keep in a dry place, protected from light and moisture, and dosage information references the package insert. Manufactured by Taro Pharmaceutical Industries Ltd.*

FDA Label Image

Principal Display Panel (200 mg Tablet Bottle Label)

Label for Carbamazepine Tablets USP 200 mg, chewable tablets with quantity of 1000 tablets. Manufactured by Taro Pharmaceutical Industries Ltd. and distributed by Taro Pharmaceuticals U.S.A., Inc. The label includes storage instructions and a note to dispense accompanying medication guide to patients. Marked Rx only.*

FDA Label Image

Container Label (Carbamazepine Chewable 200 mg)

Carbamazepine Tablets USP (Chewable) 200 mg label from Sun Pharmaceutical Industries, Inc. The label indicates each chewable tablet contains 200 mg carbamazepine and includes instructions to dispense the accompanying medication guide. The package contains 100 tablets. Storage instructions specify 20° to 25°C in a tight, light-resistant container. The product is manufactured by Taro Pharmaceutical Industries Ltd. and distributed by Sun Pharmaceutical Industries, Inc.*

FDA Label Image

Principal Display Panel (200 mg Tablet Bottle Label)

Label for Carbamazepine Extended-Release Tablets USP 100 mg, a prescription oral tablet product by Sun Pharmaceutical Industries, Inc. The label includes dosing instructions, storage conditions (20° to 25°C), and manufacturer information including Taro Pharmaceutical Industries Ltd. The package contains 100 tablets and emphasizes the tablets must be swallowed whole and dispensed in a tight container.*

FDA Label Image

Container Label (Carbamazepine 200 mg)

Label for Carbamazepine Tablets USP 200 mg, chewable oral tablets. The label indicates a package size of 100 tablets. Manufactured by Taro Pharmaceutical Industries and distributed by Sun Pharmaceutical Industries, Inc. Storage instructions and pharmacist notes are included. NDC 51672-4005-1 is visible.*

FDA Label Image

Principal Display Panel (100 mg Tablet Bottle Label)

Label for Carbamazepine Extended-Release Tablets USP 200 mg shows a package containing 100 tablets. The label includes dosing instructions, storage conditions, and manufacturer details of Taro Pharmaceutical Industries Ltd. It is marked Rx only and advises dispensing a medication guide with each prescription.*

FDA Label Image

Container Label (Carbamazepine Er 100 mg)

Carbamazepine Extended-Release Tablets USP 100 mg chewable tablets packaging label from Sun Pharmaceutical Industries, Inc. The label indicates the product contains 100 tablets. It advises that tablets must be swallowed whole and never crushed or chewed, and to dispense with the accompanying medication guide. Storage and handling instructions are provided along with manufacturer details.*

FDA Label Image

Principal Display Panel (200 mg Tablet Bottle Label)

Label for Carbamazepine Extended-Release Tablets USP 400 mg in tablet form. The label indicates 100 tablets per container, with the dosage form as extended-release tablets. It includes storage instructions and manufacturer information for Taro Pharmaceutical Industries Ltd. and Taro Pharmaceuticals U.S.A., Inc. The label features the NDC 51672-4125-1 and states Rx only.*

FDA Label Image

Container Label (Carbamazepine Er 200 mg)

Label for Carbamazepine Extended-Release Tablets USP 200 mg by Sun Pharmaceutical Industries, Inc. The label includes directions for usage, storage instructions to keep at 20° to 25°C, and warnings to protect from moisture and keep out of reach of children. The package contains 100 tablets and is marked Rx only.*

FDA Label Image

Principal Display Panel (400 mg Tablet Bottle Label)

Label for Carbamazepine Oral Suspension USP, 100 mg/5 mL, liquid medication in a 450 mL container. The label emphasizes shaking well before use and includes dosing and storage instructions. Manufactured by Taro Pharmaceutical Industries Ltd. and distributed by Taro Pharmaceuticals U.S.A., Inc.*

FDA Label Image

Container Label (Carbamazepine Er 400 mg)

Label for Carbamazepine Extended-Release Tablets USP 400 mg by Sun Pharmaceutical Industries, Inc. The label states the tablets are extended-release, must be swallowed whole, and dispensed in tight containers. It includes directions to dispense the accompanying medication guide and notes a package quantity of 100 tablets. Manufacturer is Taro Pharmaceutical Industries Ltd.*

FDA Label Image

Carton-new (Bottle Carton Label)

Carton packaging for Carbamazepine Oral Suspension, USP, 100 mg/5 mL, in a 450 mL bottle. The label is primarily white with orange and red accents and includes the TARO logo. It indicates the product is manufactured by Taro Pharmaceutical Industries Ltd. and distributed by Taro Pharmaceuticals U.S.A., Inc. The label includes important storage instructions and warnings, along with the NDC 51672-4047-4 barcode and markings.*

FDA Label Image

Carton Label (Rx5254044c450 Sun25)

Packaging label for Carbamazepine Oral Suspension USP 100 mg/5 mL, 450 mL bottle. The label includes dosing instructions, storage conditions, and a medication guide reminder. Manufactured by Taro Pharmaceutical Industries Ltd. and distributed by Sun Pharmaceutical Industries, Inc. Barcodes and regulatory numbers are visible. The label design features black and orange text on a white background.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.